Omar Khalil rejoined Santé in 2020, concentrates on the biotechnology and medical technology spaces, and manages the Boston Office.
Prior to that, he held senior leadership roles with Baxter International, Baxalta (now part of Takeda) and Kaléo, a commercial-stage biopharmaceutical company developing a novel drug delivery platform primarily focused in Allergy & Immunology. He has managed and led businesses ranging from early clinical development, commercial launch and scaling to more than $3 Billion in annual sales. He spent four years at Santé as a Principal, investing Funds I and II. Earlier in his career, he worked at McKinsey & Company in the healthcare practice, where he served leading medical device and pharmaceutical companies.
He received his MSE and BSE in Biomedical Engineering summa cum laude from the University of Michigan with a concentration in Tissue Engineering.
What attracted you to the healthcare and life sciences space?
The opportunity to work on cutting edge technology that improves people's lives.
What great advice have you received?
Tirelessly pursue opportunities that allow you to have the greatest impact.